Skip to main content
For ICBs, PCNs & provider organisations

More clinical thinking. Less preparation overhead.

A governed medication-review workspace that brings structured preparation, deterministic safety checks, pharmacist judgement and service oversight into one flow.

Pharmacist-ledmandatory professional review before release
Traceablesources, decisions, actions and audit history
Population-awareprioritisation and service-level oversight
Designed around the pharmacist

Clinical decision support that respects clinical responsibility.

Every part of the workflow is designed to make review more complete and consistent while keeping accountable judgement where it belongs.

Release clinical capacity

Prepare the medication history, safety checks and discussion points so pharmacists spend more of the appointment on judgement and shared decisions.

Keep the human accountable

A named pharmacist reviews, edits and signs the released output. The system supports the workflow; it does not become the clinician.

See delivery and variation

Population views support worklist prioritisation, activity oversight, risk distribution and service reporting across practices.

Build assurance into the workflow

Clinical-safety hazards, evidence provenance, role-based access and auditable decisions are treated as product requirements.

Protect identifiable information

Field-level encryption, pseudonymised AI processing and clear tenancy boundaries support responsible handling of health data.

A practical adoption path

Start with a bounded service question.

We would expect clinical safety, information governance, operational fit and evaluation design to be examined before scale—not after it.

01

Define the cohort and outcome

Agree who the service is for, the clinical workflow, exclusions, escalation routes and what success will be measured against.

02

Assure the deployment

Review the data flow, roles, clinical-safety case, DPIA, configuration, support model and local responsibilities.

03

Run a controlled evaluation

Start with a bounded cohort, monitor quality and workload, compare outputs and capture clinician and patient feedback.

04

Scale with evidence

Expand only when the service has demonstrated safe operation, useful outcomes and a supportable cost and workforce model.

Start a useful conversation

Tell us what your team is trying to solve.

We can discuss cohort design, pharmacist workflow, governance questions and what a responsible evaluation could look like for your organisation.

For a patient-specific question, please use the patient service or contact your usual healthcare team. Do not submit clinical information here.

We use these details only to respond to your enquiry. Please do not include patient-identifiable information.